First time JMP Clinical - aiming at utilization in data review -
Shionogi & Pharmaceutical Co., Ltd. Analysis Center Data Management division Akari Kamiya
Shionogi & Pharmaceutical Co., Ltd. Analysis Center Data Management Department Large
JMP Clinical is a useful tool for reviewing data.However, there are high hurdles to master.First of all, it is hard to read data.Even SDTM conforming to the CDISC standard may not be able to read JMP Clinical's own requirements.I think that this point is a problem that many people using JMP Clinical will fall into.If you overcome this hurdle, you will be able to use it as a tool for discovering irregular data or checking safety during testing.At the end of the trial, you can confirm with clinical trial data as well as a pharmaceutical company with a similar perspective, assuming that PMDA / FDA will review the data with JMP Clinical.If you can successfully collaborate with JMP Clinical, that user will be able to gain much knowledge.In Japan, there are few reports on JMP Clinical usage cases.In this presentation I would like to introduce case examples and exchange opinions with participants.As a result, I would like to take advantage of JMP Clinical more effectively.
